These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


191 related items for PubMed ID: 28498416

  • 1. Association of long-chain acyl-coenzyme A synthetase 5 expression in human breast cancer by estrogen receptor status and its clinical significance.
    Yen MC, Kan JY, Hsieh CJ, Kuo PL, Hou MF, Hsu YL.
    Oncol Rep; 2017 Jun; 37(6):3253-3260. PubMed ID: 28498416
    [Abstract] [Full Text] [Related]

  • 2. Systematic Analysis of Gene Expression Alterations and Clinical Outcomes for Long-Chain Acyl-Coenzyme A Synthetase Family in Cancer.
    Chen WC, Wang CY, Hung YH, Weng TY, Yen MC, Lai MD.
    PLoS One; 2016 Jun; 11(5):e0155660. PubMed ID: 27171439
    [Abstract] [Full Text] [Related]

  • 3. Long chain fatty Acyl-CoA synthetase 4 is a biomarker for and mediator of hormone resistance in human breast cancer.
    Wu X, Li Y, Wang J, Wen X, Marcus MT, Daniels G, Zhang DY, Ye F, Wang LH, Du X, Adams S, Singh B, Zavadil J, Lee P, Monaco ME.
    PLoS One; 2013 Jun; 8(10):e77060. PubMed ID: 24155918
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. 17β-estradiol-induced ACSL4 protein expression promotes an invasive phenotype in estrogen receptor positive mammary carcinoma cells.
    Belkaid A, Ouellette RJ, Surette ME.
    Carcinogenesis; 2017 Apr 01; 38(4):402-410. PubMed ID: 28334272
    [Abstract] [Full Text] [Related]

  • 6. Characterization of Acyl-CoA synthetase isoforms in pancreatic beta cells: Gene silencing shows participation of ACSL3 and ACSL4 in insulin secretion.
    Ansari IH, Longacre MJ, Stoker SW, Kendrick MA, O'Neill LM, Zitur LJ, Fernandez LA, Ntambi JM, MacDonald MJ.
    Arch Biochem Biophys; 2017 Mar 15; 618():32-43. PubMed ID: 28193492
    [Abstract] [Full Text] [Related]

  • 7. Characterization of recombinant long-chain rat acyl-CoA synthetase isoforms 3 and 6: identification of a novel variant of isoform 6.
    Van Horn CG, Caviglia JM, Li LO, Wang S, Granger DA, Coleman RA.
    Biochemistry; 2005 Feb 08; 44(5):1635-42. PubMed ID: 15683247
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Distinct transcriptional regulation of long-chain acyl-CoA synthetase isoforms and cytosolic thioesterase 1 in the rodent heart by fatty acids and insulin.
    Durgan DJ, Smith JK, Hotze MA, Egbejimi O, Cuthbert KD, Zaha VG, Dyck JR, Abel ED, Young ME.
    Am J Physiol Heart Circ Physiol; 2006 Jun 08; 290(6):H2480-97. PubMed ID: 16428347
    [Abstract] [Full Text] [Related]

  • 11. Evolution, expression profile, and regulatory characteristics of ACSL gene family in chicken (Gallus gallus).
    Tian W, Wang D, Wang Z, Jiang K, Li Z, Tian Y, Kang X, Liu X, Li H.
    Gene; 2021 Jan 05; 764():145094. PubMed ID: 32860898
    [Abstract] [Full Text] [Related]

  • 12. Human intestinal acyl-CoA synthetase 5 is sensitive to the inhibitor triacsin C.
    Kaemmerer E, Peuscher A, Reinartz A, Liedtke C, Weiskirchen R, Kopitz J, Gassler N.
    World J Gastroenterol; 2011 Nov 28; 17(44):4883-9. PubMed ID: 22171129
    [Abstract] [Full Text] [Related]

  • 13. Acyl-CoA synthetase-4, a new regulator of mTOR and a potential therapeutic target for enhanced estrogen receptor function in receptor-positive and -negative breast cancer.
    Orlando UD, Castillo AF, Dattilo MA, Solano AR, Maloberti PM, Podesta EJ.
    Oncotarget; 2015 Dec 15; 6(40):42632-50. PubMed ID: 26536660
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Levels of acyl-coenzyme A synthetase 5 in urothelial cells and corresponding neoplasias reflect cellular differentiation.
    Gaisa NT, Reinartz A, Schneider U, Klaus C, Heidenreich A, Jakse G, Kaemmerer E, Klinkhammer BM, Knuechel R, Gassler N.
    Histol Histopathol; 2013 Mar 15; 28(3):353-64. PubMed ID: 23348389
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The Diagnostic Value of ACSL1, ACSL4, and ACSL5 and the Clinical Potential of an ACSL Inhibitor in Non-Small-Cell Lung Cancer.
    Ma Y, Nenkov M, Berndt A, Abubrig M, Schmidt M, Sandhaus T, Huber O, Clement JH, Lang SM, Chen Y, Gaßler N.
    Cancers (Basel); 2024 Mar 16; 16(6):. PubMed ID: 38539505
    [Abstract] [Full Text] [Related]

  • 18. ACSL family: The regulatory mechanisms and therapeutic implications in cancer.
    Quan J, Bode AM, Luo X.
    Eur J Pharmacol; 2021 Oct 15; 909():174397. PubMed ID: 34332918
    [Abstract] [Full Text] [Related]

  • 19. Functional interaction between acyl-CoA synthetase 4, lipooxygenases and cyclooxygenase-2 in the aggressive phenotype of breast cancer cells.
    Maloberti PM, Duarte AB, Orlando UD, Pasqualini ME, Solano AR, López-Otín C, Podestá EJ.
    PLoS One; 2010 Nov 11; 5(11):e15540. PubMed ID: 21085606
    [Abstract] [Full Text] [Related]

  • 20. Role of long-chain acyl-coenzyme A synthetases in the regulation of arachidonic acid metabolism in interleukin 1β-stimulated rat fibroblasts.
    Kuwata H, Yoshimura M, Sasaki Y, Yoda E, Nakatani Y, Kudo I, Hara S.
    Biochim Biophys Acta; 2014 Jan 11; 1841(1):44-53. PubMed ID: 24095834
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.